BRAF fusions and Class I mutations were most prevalent in children, while adult gliomas harbored a broad range of BRAF alterations, including oncogenic Class II/III alterations, copy number alterations, and otherwise unclassified alterations, all of which were rare in pediatric glioma. This evidence concerns the gene BRAF and central nervous system cancer.